High-fiber Diet Reduces Bone Formation but Does Not Affect Bone Microarchitecture in Type 2 Diabetes Individuals

Overview

Journal JBMR Plus

Publisher Oxford University Press

Date 2024 Sep 10

PMID 39253598

Authors

Malak Faraj

Giulia Leanza

Johannes Krug

Francesca Cannata

Viola Viola

Biagio Zampogna

Fabrizio Russo

Giuseppe Banfi

Giovanni Lombardi

Gianluca Vadala

Laura Mangiavini

Rocco Papalia

Vincenzo Denaro

Bjorn Busse

Nicola Napoli

Affiliations

Soon will be listed here.

Abstract

Bone fragility is a recognized complication of type 2 diabetes mellitus (T2DM), increasing patient morbidity. Thus, the development of an effective intervention to prevent diabetic bone fragility is urgently needed. As lifestyle intervention represents an effective option for diabetes management, it may have an impact on bone health. While studies have shown a beneficial effect of dietary fiber in T2DM management, its effect on bone health is still unclear. Thus, we investigated the impact of a high-fiber diet on bone and glucose control in men and women with T2DM. Forty-five T2DM patients (HbA1c: 6.5% ± 0.49%, age: 74 ± 7.29 yr) scheduled for hip arthroplasty were randomly assigned to follow a high-fiber diet (38 g/day) or to make no diet changes for 12 wk. Interestingly, BMI decreased by 4% ( <.0001) and HbA1c by 3.4% ( <.0001) in the high-fiber diet group, but did not decrease in the control group. However, serum concentration of the bone formation marker procollagen type 1 amino-terminal propeptide (P1NP) decreased by 8.6 % in the high-fiber diet group ( =.0004), whereas it remained unchanged in the control group. In contrast, similar to the control group, serum concentration of the bone resorption marker C-terminal telopeptide of type I collagen (CTX) concentrations did not change in the high-fiber diet group. Bone microCT analysis revealed no changes in trabecular and cortical bone parameters between the high-fiber diet and control groups. Similarly, real-time (RT)-PCR analysis in bone tissue showed no changes in the gene expression of Wnt pathway-related genes (Sost, Dkk-1, Wnt10b, and Lef-1), bone formation markers (Runx2, Col1a1, and Ocn), and inflammatory cytokines (IL-6, IL-8, TNF-α, and IL-10) between the two groups. Our findings suggest that 12-wk high-fiber diet intervention improves metabolic outcomes in patients with T2DM. However, it may reduce bone formation without affecting bone microarchitecture or Wnt pathway regulation.

References

Holloway L, Moynihan S, Abrams S, Kent K, Hsu A, Friedlander A . Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. Br J Nutr. 2007; 97(2):365-72. DOI: 10.1017/S000711450733674X. View

Weickert M, Pfeiffer A . Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes. J Nutr. 2018; 148(1):7-12. DOI: 10.1093/jn/nxx008. View

Unnikrishnan R, Pradeepa R, Joshi S, Mohan V . Type 2 Diabetes: Demystifying the Global Epidemic. Diabetes. 2017; 66(6):1432-1442. DOI: 10.2337/db16-0766. View

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2014; 38(1):140-9. DOI: 10.2337/dc14-2441. View

Garcia-Martin A, Rozas-Moreno P, Reyes-Garcia R, Morales-Santana S, Garcia-Fontana B, Garcia-Salcedo J . Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2011; 97(1):234-41. DOI: 10.1210/jc.2011-2186. View

Trumbo P, Schlicker S, Yates A, Poos M . Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102(11):1621-30. DOI: 10.1016/s0002-8223(02)90346-9. View

Soare A, Khazrai Y, Del Toro R, Roncella E, Fontana L, Fallucca S . The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond). 2014; 11:39. PMC: 4190933. DOI: 10.1186/1743-7075-11-39. View

Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore C . The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diab Vasc Dis Res. 2013; 11(1):48-52. DOI: 10.1177/1479164113510923. View

Bryk G, Zeni Coronel M, Pellegrini G, Mandalunis P, Rio M, Pita Martin de Portela M . Effect of a combination GOS/FOS® prebiotic mixture and interaction with calcium intake on mineral absorption and bone parameters in growing rats. Eur J Nutr. 2014; 54(6):913-23. DOI: 10.1007/s00394-014-0768-y. View

10.

Slevin M, Allsopp P, Magee P, Bonham M, Naughton V, Strain J . Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. J Nutr. 2014; 144(3):297-304. DOI: 10.3945/jn.113.188144. View

11.

Wang H, Ba Y, Xing Q, Du J . Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019; 9(1):e024067. PMC: 6326306. DOI: 10.1136/bmjopen-2018-024067. View

12.

Chen Z, Stini W, Marshall J, Martinez M, Guillen-Rodriguez J, Roe D . Wheat bran fiber supplementation and bone loss among older people. Nutrition. 2004; 20(9):747-51. DOI: 10.1016/j.nut.2004.05.015. View

13.

Whisner C, Martin B, Nakatsu C, Story J, Macdonald-Clarke C, McCabe L . Soluble Corn Fiber Increases Calcium Absorption Associated with Shifts in the Gut Microbiome: A Randomized Dose-Response Trial in Free-Living Pubertal Females. J Nutr. 2016; 146(7):1298-306. DOI: 10.3945/jn.115.227256. View

14.

Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini M . Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012; 97(5):1737-44. DOI: 10.1210/jc.2011-2958. View

15.

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti M, Pulvirenti I . Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97(10):3744-50. DOI: 10.1210/jc.2012-1901. View

16.

Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, Russo F . Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes. J Bone Miner Res. 2020; 35(12):2415-2422. PMC: 8143610. DOI: 10.1002/jbmr.4153. View

17.

Shah K, Armamento-Villareal R, Parimi N, Chode S, Sinacore D, Hilton T . Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J Bone Miner Res. 2011; 26(12):2851-9. PMC: 3206995. DOI: 10.1002/jbmr.475. View

18.

Alexander C, Swanson K, Fahey G, Garleb K . Perspective: Physiologic Importance of Short-Chain Fatty Acids from Nondigestible Carbohydrate Fermentation. Adv Nutr. 2019; 10(4):576-589. PMC: 6628845. DOI: 10.1093/advances/nmz004. View

19.

Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore D . Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res. 2012; 27(5):1215-21. PMC: 3361603. DOI: 10.1002/jbmr.1560. View

20.

Zhou T, Wang M, Ma H, Li X, Heianza Y, Qi L . Dietary Fiber, Genetic Variations of Gut Microbiota-derived Short-chain Fatty Acids, and Bone Health in UK Biobank. J Clin Endocrinol Metab. 2020; 106(1):201-210. PMC: 8186524. DOI: 10.1210/clinem/dgaa740. View